Immunological incompatibility as a basis for cancer curing and vaccination

Project Information

ULISES

Grant agreement ID: 899708

DOI

10.3030/899708

Project closed

EC signature date 18 June 2020

Start date 1 October 2020

End date 30 June 2024

Funded under

• EXCELLENT SCIENCE - Future and Emerging Technologies (FET)

Total cost

€ 2 977 160,00

EU contribution

€ 2 977 160,00

Coordinated by

FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER
Spain